Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. (Q30371076)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. |
scientific article |
Statements
1 reference
Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. (English)
1 reference
Jan Skupien
1 reference
Maciej Malecki
1 reference
James H Warram
1 reference
Andrzej S Krolewski
1 reference
Monika A Niewczas
1 reference
Tomohito Gohda
1 reference
Josyf C Mychaleckyj
1 reference
Andrzej T Galecki
1 reference
Identifiers
1 reference